{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:26:39Z","timestamp":1785518799169,"version":"3.56.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00520-024-08799-3","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T10:02:21Z","timestamp":1723802541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Promoting patient-centered care in CAR-T therapy for hematologic malignancy: a qualitative meta-synthesis"],"prefix":"10.1007","volume":"32","author":[{"given":"Caiqin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuanyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"issue":"1","key":"8799_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang N, Wu J, Wang Q et al (2023) Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J 13(1):82. https:\/\/doi.org\/10.1038\/s41408-023-00853-3","journal-title":"Blood Cancer J"},{"issue":"12","key":"8799_CR2","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.3390\/ijms22126321","volume":"22","author":"P Karagianni","year":"2021","unstructured":"Karagianni P, Giannouli S, Voulgarelis M (2021) From the (Epi)genome to metabolism and vice versa; examples from hematologic malignancy. Int J Mol Sci 22(12):6321. https:\/\/doi.org\/10.3390\/ijms22126321","journal-title":"Int J Mol Sci"},{"issue":"12","key":"8799_CR3","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Fitzmaurice C, Abate D, Abbasi N et al (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5(12):1749\u20131768. https:\/\/doi.org\/10.1001\/jamaoncol.2019.2996","journal-title":"JAMA Oncol"},{"key":"8799_CR4","unstructured":"Organization WH (2017) WHO Classifcation of Tumours of Haematopoietic and Lymphoid Tissues: International Agency for Research on Cancer- World Health Organization"},{"issue":"S1","key":"8799_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/ajh.25418","volume":"94","author":"S Feins","year":"2019","unstructured":"Feins S, Kong W, Williams EF et al (2019) An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer. Am J Hematol 94(S1):S3-s9. https:\/\/doi.org\/10.1002\/ajh.25418","journal-title":"Am J Hematol"},{"issue":"5","key":"8799_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"Maude SL, Laetsch TW, Buechner J et al (2018) Tisagenlecleucel in children and young adults with b-cell lymphoblastic leukemia. N Engl J Med 378(5):439\u2013448. https:\/\/doi.org\/10.1056\/NEJMoa1709866","journal-title":"N Engl J Med"},{"issue":"8","key":"8799_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1182\/blood-2018-04-839217","volume":"132","author":"VA Chow","year":"2018","unstructured":"Chow VA, Shadman M, Gopal AK (2018) Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed\/refractory diffuse large B-cell lymphoma. Blood 132(8):777\u2013781. https:\/\/doi.org\/10.1182\/blood-2018-04-839217","journal-title":"Blood"},{"issue":"12","key":"8799_CR8","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.3390\/ijms21124303","volume":"21","author":"A Ahmad","year":"2020","unstructured":"Ahmad A (2020) CAR-T Cell Therapy. Int J Mol Sci 21(12):4303. https:\/\/doi.org\/10.3390\/ijms21124303","journal-title":"Int J Mol Sci"},{"issue":"9","key":"8799_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/d41573-022-00095-1","volume":"21","author":"AR Saez-Iba\u00f1ez","year":"2022","unstructured":"Saez-Iba\u00f1ez AR, Upadhaya S, Partridge T et al (2022) Landscape of cancer cell therapies: trends and real-world data. Nat Rev Drug Discov 21(9):631\u2013632. https:\/\/doi.org\/10.1038\/d41573-022-00095-1","journal-title":"Nat Rev Drug Discov"},{"key":"8799_CR10","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.282363","author":"MA TchernonogE","year":"2024","unstructured":"TchernonogE MA, Anota A et al (2024) Health-related quality of life in patients with hematologic malignancies treated with chimeric antigen receptor T-cell therapy: review and current progress. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2022.282363","journal-title":"Haematologica"},{"issue":"1","key":"8799_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/13696998.2023.2207742","volume":"26","author":"W Wu","year":"2023","unstructured":"Wu W, Ding S, Mingming Z et al (2023) Cost effectiveness analysis of CAR-T cell therapy for patients with relapsed\/refractory multiple myeloma in China. J Med Econ 26(1):701\u2013709. https:\/\/doi.org\/10.1080\/13696998.2023.2207742","journal-title":"J Med Econ"},{"issue":"6","key":"8799_CR12","doi-asserted-by":"publisher","first-page":"151216","DOI":"10.1016\/j.soncn.2021.151216","volume":"37","author":"MS Whisenant","year":"2021","unstructured":"Whisenant MS, Srour SA, Williams LA et al (2021) the unique symptom burden of patients receiving CAR T-cell therapy. Semin Oncol Nurs 37(6):151216. https:\/\/doi.org\/10.1016\/j.soncn.2021.151216","journal-title":"Semin Oncol Nurs"},{"issue":"3","key":"8799_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40487-023-00232-9","volume":"11","author":"TJ Bixby","year":"2023","unstructured":"Bixby TJ, Brittle CJ, Mangan PA et al (2023) Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth Interviews. Oncol Ther 11(3):303\u2013312. https:\/\/doi.org\/10.1007\/s40487-023-00232-9","journal-title":"Oncol Ther"},{"key":"8799_CR14","doi-asserted-by":"publisher","unstructured":"Keykhaei M, Masinaei M, Mohammadi E et al (2021) A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990\u20132017. Exp Hematol Oncol 10(1). https:\/\/doi.org\/10.1186\/s40164-021-00198-2","DOI":"10.1186\/s40164-021-00198-2"},{"issue":"5","key":"8799_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00520-023-07763-x","volume":"31","author":"Y Mao","year":"2023","unstructured":"Mao Y, Huang L, Ruan H et al (2023) Patients\u2019 experience with chimeric antigen receptor T-cell therapy for DLBCL in China: a qualitative study. Support Care Cancer 31(5):303. https:\/\/doi.org\/10.1007\/s00520-023-07763-x","journal-title":"Support Care Cancer"},{"key":"8799_CR16","doi-asserted-by":"publisher","first-page":"102479","DOI":"10.1016\/j.ctrv.2022.102479","volume":"111","author":"R Hernani","year":"2022","unstructured":"Hernani R, Benzaqu\u00e9n A, Solano C (2022) Toxicities following CAR-T therapy for hematological malignancies. Cancer Treat Rev 111:102479. https:\/\/doi.org\/10.1016\/j.ctrv.2022.102479","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"8799_CR17","doi-asserted-by":"publisher","first-page":"E802","DOI":"10.1097\/HS9.0000000000000802","volume":"6","author":"F Efficace","year":"2022","unstructured":"Efficace F, Cannella L, Sparano F et al (2022) Chimeric antigen receptor t-cell therapy in hematologic malignancies and patient-reported outcomes: a scoping review. HemaSphere 6(12):E802. https:\/\/doi.org\/10.1097\/HS9.0000000000000802","journal-title":"HemaSphere"},{"key":"8799_CR18","doi-asserted-by":"publisher","unstructured":"Kamal M, Joseph J, Greenbaum U et al (2021) Patient-reported outcomes for cancer patients with hematological malignancies undergoing chimeric antigen receptor t cell therapy: a systematic review. Transplant Cell Ther 27(5). https:\/\/doi.org\/10.1016\/j.jtct.2021.01.003","DOI":"10.1016\/j.jtct.2021.01.003"},{"key":"8799_CR19","doi-asserted-by":"publisher","unstructured":"Shah N, Delforge M, San-Miguel J et al (2022) Patient experience before and after treatment with idecabtagene vicleucel (ide-cel, bb2121): qualitative analysis of patient interviews in the KarMMa trial. Leukemia Res 120. https:\/\/doi.org\/10.1016\/j.leukres.2022.106921","DOI":"10.1016\/j.leukres.2022.106921"},{"issue":"12","key":"8799_CR20","doi-asserted-by":"publisher","first-page":"e802","DOI":"10.1097\/HS9.0000000000000802","volume":"6","author":"F Efficace","year":"2022","unstructured":"Efficace F, Cannella L, Sparano F et al (2022) Chimeric antigen receptor T-cell therapy in hematologic malignancies and patient-reported outcomes: a scoping review. HEMASPHERE 6(12):e802. https:\/\/doi.org\/10.1097\/HS9.0000000000000802","journal-title":"HEMASPHERE"},{"issue":"1","key":"8799_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40487-021-00174-0","volume":"10","author":"R Cheng","year":"2022","unstructured":"Cheng R, Scippa K, Locke FL et al (2022) Patient perspectives on health-related quality of life in diffuse large B-cell lymphoma treated with car T-cell therapy: a qualitative study. Oncol Ther 10(1):123\u2013141. https:\/\/doi.org\/10.1007\/s40487-021-00174-0","journal-title":"Oncol Ther"},{"key":"8799_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2288-12-181","volume":"12","author":"A Tong","year":"2012","unstructured":"Tong A, Flemming K, McInnes E et al (2012) Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol 12:181. https:\/\/doi.org\/10.1186\/1471-2288-12-181","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"8799_CR23","first-page":"167","volume":"56","author":"JJ Riva","year":"2012","unstructured":"Riva JJ, Malik KM, Burnie SJ et al (2012) What is your research question? An introduction to the PICOT format for clinicians. J Can Chiropr Assoc 56(3):167\u2013171","journal-title":"J Can Chiropr Assoc"},{"key":"8799_CR24","first-page":"2453","volume":"44","author":"P Huston","year":"1998","unstructured":"Huston P, Rowan M (1998) Qualitative studies. Their role in medical research. Can Fam Physician 44:2453\u20132458","journal-title":"Can Fam Physician"},{"key":"8799_CR25","doi-asserted-by":"publisher","first-page":"104030","DOI":"10.1016\/j.ijnurstu.2021.104030","volume":"122","author":"LM Boehm","year":"2021","unstructured":"Boehm LM, Jones AC, Selim AA et al (2021) Delirium-related distress in the ICU: A qualitative meta-synthesis of patient and family perspectives and experiences. Int J Nurs Stud 122:104030. https:\/\/doi.org\/10.1016\/j.ijnurstu.2021.104030","journal-title":"Int J Nurs Stud"},{"issue":"6","key":"8799_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/wvn.12258","volume":"14","author":"RK Buccheri","year":"2017","unstructured":"Buccheri RK, Sharifi C (2017) Critical appraisal tools and reporting guidelines for evidence-based practice. Worldviews Evid Based Nurs 14(6):463\u2013472. https:\/\/doi.org\/10.1111\/wvn.12258","journal-title":"Worldviews Evid Based Nurs"},{"key":"8799_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2288-8-21","volume":"8","author":"S Atkins","year":"2008","unstructured":"Atkins S, Lewin S, Smith H et al (2008) Conducting a meta-ethnography of qualitative literature: lessons learnt. BMC Med Res Methodol 8:21. https:\/\/doi.org\/10.1186\/1471-2288-8-21","journal-title":"BMC Med Res Methodol"},{"key":"8799_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-8-45","volume":"8","author":"J Thomas","year":"2008","unstructured":"Thomas J, Harden A (2008) Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol 8:45. https:\/\/doi.org\/10.1186\/1471-2288-8-45","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"8799_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.clml.2022.10.001","volume":"23","author":"AD Cohen","year":"2023","unstructured":"Cohen AD, Hari P, Htut M et al (2023) Patient perceptions regarding ciltacabtagene autoleucel treatment: qualitative evidence from interviews with patients with relapsed\/refractory multiple myeloma in the CARTITUDE-1 Study. Clin Lymphoma Myeloma Leuk 23(1):68\u201377. https:\/\/doi.org\/10.1016\/j.clml.2022.10.001","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"8799_CR30","doi-asserted-by":"publisher","unstructured":"Delforge M, Otero PR, Shah N et al (2023) Analysis of patient-reported experiences up to 2 years after receiving idecabtagene vicleucel (ide-cel, bb2121) for relapsed or refractory multiple myeloma: Longitudinal findings from the phase 2 KarMMa trial. Leukemia Res 129. https:\/\/doi.org\/10.1016\/j.leukres.2023.107074","DOI":"10.1016\/j.leukres.2023.107074"},{"issue":"1","key":"8799_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13023-023-02680-y","volume":"18","author":"I Litchfield","year":"2023","unstructured":"Litchfield I, Calvert MJ, Kinsella F et al (2023) \u201cI just wanted to speak to someone- and there was no one\u2026\u201d: using Burden of Treatment Theory to understand the impact of a novel ATMP on early recipients. Orphanet J Rare Dis 18(1):86. https:\/\/doi.org\/10.1186\/s13023-023-02680-y","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"8799_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/02692163221138880","volume":"37","author":"CL Stenson","year":"2023","unstructured":"Stenson CL, Vidrine J, Dewhurst F et al (2023) A qualitative service evaluation of patient and caregiver experiences of CAR-T therapy: Recommendations for service development and implications for palliative care teams. Palliat Med 37(2):215\u2013220. https:\/\/doi.org\/10.1177\/02692163221138880","journal-title":"Palliat Med"},{"issue":"4","key":"8799_CR33","doi-asserted-by":"publisher","first-page":"254.e251","DOI":"10.1016\/j.jtct.2023.01.004","volume":"29","author":"IM Akinola","year":"2023","unstructured":"Akinola IM, Cusatis R, Pasquini MC et al (2023) Multi-stakeholder qualitative interviews to inform measurement of patient reported outcomes after CAR-T. Transplant Cell Ther 29(4):254.e251-254.e259. https:\/\/doi.org\/10.1016\/j.jtct.2023.01.004","journal-title":"Transplant Cell Ther"},{"key":"8799_CR34","doi-asserted-by":"publisher","unstructured":"Jenei K, Burgess M, Peacock S et al (2021) Experiences and perspectives of individuals accessing CAR-T cell therapy: A qualitative analysis of online Reddit discussions. J Cancer Policy 30. https:\/\/doi.org\/10.1016\/j.jcpo.2021.100303","DOI":"10.1016\/j.jcpo.2021.100303"},{"issue":"11","key":"8799_CR35","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s40273-022-01180-4","volume":"40","author":"M Wilson","year":"2022","unstructured":"Wilson M, Thavorn K, Hawrysh T et al (2022) Engaging patients and caregivers in an early health economic evaluation: discerning treatment value based on lived experience. Pharmacoeconomics 40(11):1119\u20131130. https:\/\/doi.org\/10.1007\/s40273-022-01180-4","journal-title":"Pharmacoeconomics"},{"key":"8799_CR36","doi-asserted-by":"publisher","unstructured":"Elsman E BM, Mokkink LB, Terwee CB et al (2024) Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024. J Clin Epidemiol 111422. https:\/\/doi.org\/10.1016\/j.jclinepi.2024.111422","DOI":"10.1016\/j.jclinepi.2024.111422"},{"issue":"2","key":"8799_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/bjhp.12544","volume":"27","author":"S Cockle","year":"2022","unstructured":"Cockle S, Ogden J (2022) Patients\u2019 expectations of cancer treatment and their perceived link to subsequent experiences: A qualitative study. Br J Health Psychol 27(2):267\u2013282. https:\/\/doi.org\/10.1111\/bjhp.12544","journal-title":"Br J Health Psychol"},{"key":"8799_CR38","doi-asserted-by":"publisher","first-page":"152431","DOI":"10.1016\/j.comppsych.2023.152431","volume":"127","author":"LA Basedow","year":"2023","unstructured":"Basedow LA, Fischer A, Benson S et al (2023) The influence of psychological traits and prior experience on treatment expectations. Compr Psychiatry 127:152431. https:\/\/doi.org\/10.1016\/j.comppsych.2023.152431","journal-title":"Compr Psychiatry"},{"issue":"2","key":"8799_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11136-016-1397-0","volume":"26","author":"DT Eton","year":"2017","unstructured":"Eton DT, Yost KJ, Lai JS et al (2017) Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden. Qual Life Res 26(2):489\u2013503. https:\/\/doi.org\/10.1007\/s11136-016-1397-0","journal-title":"Qual Life Res"},{"key":"8799_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2147\/ppa.S58014","volume":"8","author":"JL Ridgeway","year":"2014","unstructured":"Ridgeway JL, Egginton JS, Tiedje K et al (2014) Factors that lessen the burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Prefer Adherence 8:339\u2013351. https:\/\/doi.org\/10.2147\/ppa.S58014","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"8799_CR41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ijnurstu.2005.06.004","volume":"43","author":"AM Williams","year":"2006","unstructured":"Williams AM, Irurita VF (2006) Emotional comfort: the patient\u2019s perspective of a therapeutic context. Int J Nurs Stud 43(4):405\u2013415. https:\/\/doi.org\/10.1016\/j.ijnurstu.2005.06.004","journal-title":"Int J Nurs Stud"},{"issue":"10","key":"8799_CR42","doi-asserted-by":"publisher","first-page":"E217","DOI":"10.1503\/cmaj.151171","volume":"188","author":"C Zimmermann","year":"2016","unstructured":"Zimmermann C, Swami N, Krzyzanowska M et al (2016) Perceptions of palliative care among patients with advanced cancer and their caregivers. CMAJ 188(10):E217-e227. https:\/\/doi.org\/10.1503\/cmaj.151171","journal-title":"CMAJ"},{"issue":"6","key":"8799_CR43","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/j.1365-2648.1994.tb01202.x","volume":"19","author":"KY Kolcaba","year":"1994","unstructured":"Kolcaba KY (1994) A theory of holistic comfort for nursing. J Adv Nurs 19(6):1178\u20131184. https:\/\/doi.org\/10.1111\/j.1365-2648.1994.tb01202.x","journal-title":"J Adv Nurs"},{"issue":"1","key":"8799_CR44","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1097\/ncc.0000000000001223","volume":"47","author":"H Ruan","year":"2024","unstructured":"Ruan H, Sun J, Zhao K et al (2024) Subjective Toxicity Profiles of Children With Cancer During Treatment: A Latent Class Analysis. Cancer Nurs 47(1):E1-e9. https:\/\/doi.org\/10.1097\/ncc.0000000000001223","journal-title":"Cancer Nurs"},{"issue":"1","key":"8799_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/cncr.29702","volume":"122","author":"MS Weaver","year":"2016","unstructured":"Weaver MS, Reeve BB, Baker JN et al (2016) Concept-elicitation phase for the development of the pediatric patient-reported outcome version of the Common Terminology Criteria for Adverse Events. Cancer 122(1):141\u2013148. https:\/\/doi.org\/10.1002\/cncr.29702","journal-title":"Cancer"},{"issue":"3","key":"8799_CR46","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/tbm\/ibz025","volume":"9","author":"FWK Harper","year":"2019","unstructured":"Harper FWK, Albrecht TL, Trentacosta CJ et al (2019) Understanding differences in the long-term psychosocial adjustment of pediatric cancer patients and their parents: an individual differences resources model. Transl Behav Med 9(3):514\u2013522. https:\/\/doi.org\/10.1093\/tbm\/ibz025","journal-title":"Transl Behav Med"},{"issue":"4","key":"8799_CR47","doi-asserted-by":"publisher","first-page":"452.e451","DOI":"10.1016\/j.jtct.2024.01.063","volume":"30","author":"A Barata","year":"2024","unstructured":"Barata A, Dhawale T, Newcomb RA et al (2024) Quality of life and prognostic awareness in caregivers of patients receiving chimeric antigen receptor T cell therapy. Transplant Cell Ther 30(4):452.e451-452.e411. https:\/\/doi.org\/10.1016\/j.jtct.2024.01.063","journal-title":"Transplant Cell Ther"},{"key":"8799_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.critrevonc.2017.12.011","volume":"122","author":"S Oberoi","year":"2018","unstructured":"Oberoi S, Robinson PD, Cataudella D et al (2018) Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis of randomized trials. Crit Rev Oncol Hematol 122:52\u201359. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.12.011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"8799_CR49","doi-asserted-by":"publisher","first-page":"jrm00163","DOI":"10.2340\/16501977-2810","volume":"53","author":"B Amatya","year":"2021","unstructured":"Amatya B, Khan F, Lew TE et al (2021) Rehabilitation in patients with lymphoma: An overview of Systematic Reviews. J Rehabil Med 53(3):jrm00163. https:\/\/doi.org\/10.2340\/16501977-2810","journal-title":"J Rehabil Med"},{"issue":"6","key":"8799_CR50","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ctrv.2013.01.001","volume":"39","author":"S Persoon","year":"2013","unstructured":"Persoon S, Kersten MJ, van der Weiden K et al (2013) Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: a systematic review and meta-analysis. Cancer Treat Rev 39(6):682\u2013690. https:\/\/doi.org\/10.1016\/j.ctrv.2013.01.001","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"8799_CR51","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s11912-022-01240-0","volume":"24","author":"O Obaisi","year":"2022","unstructured":"Obaisi O, Fontillas RC, Patel K et al (2022) Rehabilitation Needs for Patients Undergoing CAR T-Cell Therapy. Curr Oncol Rep 24(6):741\u2013749. https:\/\/doi.org\/10.1007\/s11912-022-01240-0","journal-title":"Curr Oncol Rep"},{"key":"8799_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-publhealth-040218-044008","volume":"40","author":"JP Allegrante","year":"2019","unstructured":"Allegrante JP, Wells MT, Peterson JC (2019) Interventions to Support Behavioral Self-Management of Chronic Diseases. Annu Rev Public Health 40:127\u2013146. https:\/\/doi.org\/10.1146\/annurev-publhealth-040218-044008","journal-title":"Annu Rev Public Health"},{"issue":"11","key":"8799_CR53","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/oncolo\/oyad100","volume":"28","author":"A Carmona-Bayonas","year":"2023","unstructured":"Carmona-Bayonas A, Rodriguez-Gonzalez A, Garc\u00eda-Garc\u00eda T et al (2023) Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data NEOetic Study Oncol 28(11):986\u2013995. https:\/\/doi.org\/10.1093\/oncolo\/oyad100","journal-title":"Data NEOetic Study Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08799-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08799-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08799-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T10:04:46Z","timestamp":1723802686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08799-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["8799"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08799-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a meta-synthesis of qualitative literature. The Research Ethics Committee of The Second Affiliated Hospital of Zhejiang University School of Medicine has confirmed that no ethical approval and ethics accordance is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"591"}}